Thryotoxicosis (55 min.)

$50.00

<< Return to Courses

In this presentation, Dr. Jessica Smith distinguishes thyrotoxicosis from hyperthyroidism, formulates a differential diagnosis for thyrotoxicosis, and reviews the investigations required to make the diagnosis. Furthermore, Dr. Smith discusses treatment options, risks, and benefits of each therapy for Graves’ disease (and neonatal Graves’ disease).

Category:

Description

Jessica Smith, MD
Associate Medical Director, Thyroid Center; Attending Physician, Division of Endocrinology

Assistant Professor of Pediatrics, Harvard Medical School

 

 

In this presentation, Dr. Jessica Smith distinguishes thyrotoxicosis from hyperthyroidism, formulates a differential diagnosis for thyrotoxicosis, and reviews the investigations required to make the diagnosis. Furthermore, Dr. Smith discusses treatment options, risks, and benefits of each therapy for Graves’ disease (and neonatal Graves’ disease).


Learning Objectives: 

At the conclusion of this educational program, learners will be able to:

  1. Distinguish thyrotoxicosis from hyperthyroidism.
  2. Formulate a differential diagnosis for thyrotoxicosis.
  3. Understand the investigations required to make the diagnosis.
  4. Discuss treatment options, risks, and benefits of each therapy for Graves’ disease (and neonatal Graves’ disease).

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician

Boston Children’s Hospital designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Nurse

Boston Children’s Hospital designates this activity for 1.0 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity. 

Disclosure Policy 
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients: 

Jessica Smith, MD: None

Additional information

Credit Type

,

Duration

Format

Topic

,

Expiration Date

Release Date